Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.39% to 7727.41, DAX +0.20% to 16739.16, CAC40 +0.06% to 7573.10, STOXX 600 +0.22% to 478.66

Dec 27 ,2023

  • Synopsis:

    • European equity markets ended mostly higher in very quiet session. Norway +0.8%, Belgium and Austria +0.7%, Finland +0.6% led the outperformers whilst Switzerland (0.4%), Denmark and Portugal (0.1%) led the underperformers.

    • Attention on EU preparing up to €20B for Ukraine using debt structure that could sidestep Hungary veto of further financial aid (FT). Member states would issue guarantees to the EU budget, enabling EU Commission to borrow up to €20B on capital markets. Success is not certain, as some countries would need parliamentary approval.

    • In political developments, Spanish PM Pedro Sánchez announced on Wednesday a windfall tax extension for another year on both banks and energy companies. Also extends measures to freeze VAT on basic food goods however, tax cuts on energy bills will return to normal from April. In the UK, more speculation over potential UK tax cuts ahead of general election next year. Treasury said Budget to be held on 6-Mar.

    • No macro data of note in Europe. Industry numbers from UK showed footfall picked up on Boxing Day but visit to stores remained well below pre-Covid levels as many stores did not open. Christmas Eve sales numbers also impacted by Sunday trading. Elsewhere, German business group DIHK remains downbeat over prospects for German economy next year.

    • Focus also on gas prices raising. Bloomberg reported on a pickup in European gas prices, with futures in Dutch market up as much as 6% in early trade amid increase in Middle East tensions. Concerns over wider regional war related to Israel-Gaza conflict continue.

    • In corporate news, ADLER Group (ADJ.GR) shares traded notably higher as BaFin concluded examination of ADLER Real Estate's financial statements 2019 to 2021. Elsewhere, Nigeria's competition commission orders British American Tobacco (BATS.LN) to pay $110M fine following allegations of market dominance abuse and infringement of public health regulations. GenSight Biologics (SIGHT.FP) issued a business and financial update. Company also said is also advancing on a number of discussions with potential partners on strategic opportunities, including a possible merger, acquisition or licensing deal, assessed as one of the relevant options to move forward.

    • Further on M&A front, Adani Green Energy announced completion of the 1,050 MW joint venture (JV) with TotalEnergies (TTE.FP). EQT Fund Management updated on Dechra Pharmaceuticals (DPH.LN) acquisition. Aviva (AV.LN) noted additional proceeds of c.£80M expected from exit of Singlife joint venture. Apax (KCT.LN) said it is considering options regarding Kin + Carta recommended cash offer made by Ken Bidco. Silver Lake selling further units of Software AG (SOW.GR) Handelsblatt reported.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Real Estate+0.71%, Technology +0.60%, Oil & Gas +0.61%, Banks +0.53%, Financial Svcs +0.34%, Food & Beverage +0.31%, Ind Goods & Svcs +0.30%, Basic Resources +0.27%, Construct & Mtls +0.26%,

      • Underperformers

        • Telecom (0.35%), Utilities (0.10%), Autos & Parts (0.07%), Persnl & HHold Goods (0.03%), Media +0.03%, Health Care +0.06%, Insurance +0.09%, Chemicals +0.14%, Travel & Leisure +0.16%, Retail +0.20%,

    • Macro/Peripheral markets:

      • EU

        • EU readies €20B plan B to fund Ukraine - FT

        • Euro rises to highest in five months as Fed bets fuel risk rally - Bloomberg

      • NATO

        • Turkish parliamentary committee approves Sweden's NATO application - FT

      • Oil

        • Oil steady as market monitors Red Sea developments - Reuters

      • UK

        • UK quietly drops Brexit law to return to imperial measurements - FT

        • No10 plans to end inheritance tax in spring ahead of election - Telegraph

        • Worried Tories promise help for first-time buyers - Times

        • Treasury says 2024 Budget to be held on 6 March - BBC

        • UK post-Christmas shopping provides some cheer for retailers - Reuters

      • France

        • The waning power of Emmanuel Macron - FT

      • Spain

        • Spain extends measures put in place to ease inflation hit - Bloomberg

        • Spanish PM open to creation of new EU mission to protect vessels in Red Sea - Reuters

      • Italy

        • Never said Italy would ratify ESM says Giorgetti - Ansa

      • Belgium

        • Belgium Central Bank Chief renewal on hold over political deadlock - Bloomberg

      • Serbia

        • Serbia cracks down on protests amid 'election fraud' outcry - Politico

    • Company news:

      • Notable Gainers

        • +67.5% HZM.LN (Horizonte minerals) -- announces interim $20M funding package

        • +21.5% BUR.LN (Burford Capital) -- Argentina's President Milei suggests issuing perpetual bond to pay $16B damages award in YPF nationalization litigation -- Bloomberg (yesterday post-close)

        • +17.7% ADJ.GR (ADLER Group) --concludes examination of ADLER Real Estate's financial statements 2019 to 2021

        • +10.5% SANION.SS (Saniona) -- strengthens epilepsy pipeline with selection of SAN2355 as clinical candidate

        • +4.1% FYB.GR (Formycon) -- announces EMA acceptance of the MAA for FYB203, a biosimilar candidate to Eylea (Aflibercept)

        • +4.4% AMG.NA (AMG Critical Materials) -- announces that LIVA Power Management Systems GmbH, a wholly owned subsidiary of AMG Critical Materials N.V. has agreed to acquire the Vanadium Redox Flow Battery activities from J.M. VOITH SE

        • +3.7% CNE.LN (Capricorn Energy) -- updates on Senegal contingent payment

        • +2.6% AAL.LN (Anglo American) -- moving "at pace" to sell up-to-49% stake in Woodsmith fertiliser mine - London Times

      • Notable Decliners

        • -13.8% KURN.SW (Kuros Biosciences) -- announces results from two prospective Randomized clinical trials: structure and MAXA

        • -2.4% NIBE.B.SS (NIBE Industrier) -- to hold from buy at Carnegie Securities

        • -2.0% EQLS.LN (Equals Group PLC) -- says current trading continues to be in line with the board's expectations and the board remains confident in the longer-term growth prospects of the business; deadlne moved to 24-Jan-24

        • -1.3% PGHN.SW (Partners Group Holding) -- to Reduce from Buy at Baader Helvea

    • EU companies reporting tomorrow:

      • No earnings scheduled

Data:

  • Economics:

    • Norway Nov Retail Sales +0.4% m/m vs consensus +0.3% and prior revised to +0.4% from +0.6%

    • Switzerland December ZEW expectations (23.7) vs prior (29.6)

  • Markets:

    • WTI Crude (Feb 24): ($0.75) or (0.99%) to $74.82

    • €-$ +0.0073 or +0.66% to 1.1118

    • £-$ +0.0074 or +0.58% to 1.2799

    • €-£ +0.0010 to 0.8688

    • S&P 500 (0.07%)

    • Performance year-to-date

    • FTSE 100: +3.66%

    • DAX: +20.17%

    • CAC: +16.92%

    • MIB: +28.17%

    • Stoxx 600: +12.66%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE